<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01719146</url>
  </required_header>
  <id_info>
    <org_study_id>R01DK093832-01A1</org_study_id>
    <secondary_id>R01DK093832</secondary_id>
    <nct_id>NCT01719146</nct_id>
  </id_info>
  <brief_title>Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease</brief_title>
  <official_title>Computational Approach to Personalized Anemia Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to prospectively collect data on doses of Erythropoietic
      Stimulating Agents and Intravenous Iron, and the markers of erythropoietic activity and iron
      status. These data will be used to derive mathematical models which will subsequently guide
      dosing of both agents, such that a desired therapeutic outcome is achieved in every patient,
      while minimizing patient exposure to both agents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data will be collected from 120 subjects undergoing hemodialysis treatment at 3 clinical
      sites across United States (40 per site).5.5 mL blood specimen will be drawn during midweek
      treatment (Wed/Thu) to measure:

      Hemoglobin Concentration Hematocrit Red Blood Cell Count Platelet Count Reticulocyte
      Percentage Reticulocyte Hemoglobin Mean Cellular Hemoglobin Mean Cellular Hemoglobin
      Concentration Mean Cell Volume Red Cell Volume Distribution Width Mean Platelet Volume Serum
      Iron Serum Ferritin Transferrin Saturation Hepcidin Soluble Transferrin Receptor

      Weekly ESA and Iron dose delivered will also be recorded.

      From these data:

        1. a mathematical model will be established to find biomarkers most descriptive with
           respect to erythropoiesis-iron synergy,

        2. a mathematical model will be established to correlate iron dose with iron markers.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin Concentration (g/dL)</measure>
    <time_frame>52 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reticulocyte Percentage (%)</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reticulocyte Hemoglobin Equivalent, RetHe (pg)</measure>
    <time_frame>52 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Transferrin Saturation (%)</measure>
    <time_frame>52 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Serum Ferritin (ng/mL)</measure>
    <time_frame>52 weeks</time_frame>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anemia of End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>UofL Subjects</arm_group_label>
    <description>Subjects undergoing Specimen Collection at University Kidney Center, University of Louisville, Louisville, KY</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Duke Subjects</arm_group_label>
    <description>Subjects undergoing Specimen Collection at Duke University, Durham, NC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WNERTA Subjects</arm_group_label>
    <description>Subject undergoing Specimen Collection at Western New England Renal and Transplant Associates, Springfield, MA</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Specimen collection</intervention_name>
    <description>At the beginning of each midweek hemodialysis session, a blood specimen (4 mL) will be drawn from the study subject. Out of this specimen a 1 mL serum sample will be frozen and stored. A 3 mL blood sample will be shipped overnight to WNERTA for laboratory testing.</description>
    <arm_group_label>UofL Subjects</arm_group_label>
    <arm_group_label>Duke Subjects</arm_group_label>
    <arm_group_label>WNERTA Subjects</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, serum will be extracted and frozen for further analysis. Serum will be retained for up
      to 60 days.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        End Stage Renal Disease Patients undergoing hemodialysis treatments at:

          1. University Kidney Center, Louisville, KY

          2. Duke University, Durham, NC

          3. WNERTA, Springfield, MA
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  receiving or expected to receive ESA

        Exclusion Criteria:

          -  life expectancy less than 12 months

          -  frequent (once or more per month w/in last 6 months) uncontrolled blood loss

          -  frequent (once or more per month w/in last 6 months) hospitalization

          -  frequent (once or more per month w/in last 6 months) access complications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam E Gaweda, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Louisville, University Kidney Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western New England Renal and Transplant Associates</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2012</study_first_submitted>
  <study_first_submitted_qc>October 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2012</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Adam Edward Gaweda</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Anemia</keyword>
  <keyword>Chronic Kidney Disease</keyword>
  <keyword>Erythropoiesis Stimulating Agents</keyword>
  <keyword>Erythropoietin</keyword>
  <keyword>Iron</keyword>
  <keyword>Iron Deficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epoetin Alfa</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

